RGT 0.00% 30.0¢ argent biopharma limited

Ann: Response to ASX Aware Query, page-6

  1. 13,769 Posts.
    lightbulb Created with Sketch. 2317
    To be honest, I am not totally convinced that cannabis will be the future choice in pharmaceuticals.

    Lots of hype around the product 5 years ago - and all cannabis stocks peaked at that time. Most have now gone well back from their highs. I believe cannabis in medicine has had its day and whatever benefits it brings now into the arena will largely be the limit.

    MXC was excellent at self promotion - but rarely accurate. It is difficult to see their pipelines amounting to anything substantial - and their current financial position can only be described as precarious.

    I never give advice to others to buy or sell shares in any company - and I won't start now. However, for those who do hold, I think the time has come to look at your investment in MXC very closely with balanced and an unemotional eye. MXC is looking a little shaky. If you do have queries, then push the company for answers - you don't know how long the opportunity to do so will last.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $14.52M
Open High Low Value Volume
28.5¢ 30.0¢ 28.5¢ $290 1.008K

Buyers (Bids)

No. Vol. Price($)
1 1456 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 2307 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.